COVID-19 risk is not increased by breast cancer treatment

Written by Ryan Gilroy (Future Science Group)

COVID-19 risk

Immunosuppressive cancer therapies do not increase the risk of COVID-19 infection or death compared to therapies of minimal impact on the immune system. Data from NYU Langone Health and the Perlmutter Cancer Center (PCC) (both NY, USA) challenge initial concerns that such treatments were too dangerous to continue during the pandemic. The investigation of over 3000 women treated for breast cancer at the height of the COVID-19 pandemic in New York City discovered that only 64 contracted the virus. Of this group, 10 died from COVID-19, a number low for the age group, regardless of cancer. Notably, those receiving immunosuppressive...

To view this content, please register now for access

It's completely free